This post was originally published on this site
Stryker announced earnings per share of $2.25 on revenue of $4.29B. Analysts polled by Investing.com anticipated EPS of $2.13 on revenue of $4.14B.
Stryker shares are up 50% from the beginning of the year, still down 0.48% from its 52 week high of $269.64 set on July 27. They are outperforming the Nasdaq 100 which is up 16.05% from the start of the year.
Stryker’s report follows an earnings beat by J&J on July 21, who reported EPS of $2.48 on revenue of $23.31B, compared to forecasts EPS of $2.29 on revenue of $22.49B.
UnitedHealth had beat expectations on July 15 with second quarter EPS of $4.7 on revenue of $71.32B, compared to forecast for EPS of $4.43 on revenue of $69.51B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
